{"transactions":[{"id":4629432,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2026-10-05T16:18:10.000Z","date":"2026-10-01","kind":"exercise","planned":false,"acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."}],"balance_after":250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001193125-26-413742","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526413742/ownership.xml","form_type":"4"}},{"id":4629431,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2026-10-05T16:18:10.000Z","date":"2026-10-01","kind":"exercise","planned":false,"acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28364.621,"source":{"system":"sec-edgar","filing":"0001193125-26-413742","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526413742/ownership.xml","form_type":"4"}},{"id":4629430,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2026-10-05T16:18:10.000Z","date":"2026-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":276,"price":9.76,"value":2693.76,"ownership":{"direct":true},"balance_after":28088.621,"source":{"system":"sec-edgar","filing":"0001193125-26-413742","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526413742/ownership.xml","form_type":"4"}},{"id":697378,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2026-08-04T14:27:07.000Z","date":"2026-08-01","kind":"exercise","planned":false,"acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":950,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001193125-26-331829","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312526331829/ownership.xml","form_type":"4"}},{"id":697377,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2026-08-04T14:27:07.000Z","date":"2026-08-01","kind":"exercise","planned":false,"acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27763.621,"source":{"system":"sec-edgar","filing":"0001193125-26-331829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312526331829/ownership.xml","form_type":"4"}},{"id":697376,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2026-08-04T14:27:07.000Z","date":"2026-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":99,"price":10.64,"value":1053.36,"ownership":{"direct":true},"balance_after":27664.621,"source":{"system":"sec-edgar","filing":"0001193125-26-331829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312526331829/ownership.xml","form_type":"4"}},{"id":793964,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2026-05-04T20:37:33.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":1200,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001193125-26-204136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312526204136/ownership.xml","form_type":"4"}},{"id":793963,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2026-05-04T20:37:33.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27610.621,"source":{"system":"sec-edgar","filing":"0001193125-26-204136","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312526204136/ownership.xml","form_type":"4"}},{"id":793962,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2026-05-04T20:37:33.000Z","date":"2026-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":97,"price":14.07,"value":1364.79,"ownership":{"direct":true},"balance_after":27513.621,"source":{"system":"sec-edgar","filing":"0001193125-26-204136","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312526204136/ownership.xml","form_type":"4"}},{"id":901260,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Performance Shares","published_at":"2026-02-17T16:07:05.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":33490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests following the conclusion of a three-year performance period that began on January 1, 2026 and ends on December 31, 2028 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, on December 31, 2028, following the conclusion of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (\"ROIC\") among the Bloomberg Peer Group (\"BPG\"), 100% of the award will vest if the Company is in the top 55th percentile of ROIC among the BPG, and 175% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile of ROIC (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile of ROIC (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests following the conclusion of a three-year performance period that began on January 1, 2026 and ends on December 31, 2028 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, on December 31, 2028, following the conclusion of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (\"ROIC\") among the Bloomberg Peer Group (\"BPG\"), 100% of the award will vest if the Company is in the top 55th percentile of ROIC among the BPG, and 175% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."}],"balance_after":33490,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":33490},"source":{"system":"sec-edgar","filing":"0001193125-26-053614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312526053614/ownership.xml","form_type":"4"}},{"id":951945,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Performance Shares","published_at":"2026-01-05T20:18:37.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":false,"shares":24952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2023, as disclosed in the Reporting Person's Form 4 filing on February 21, 2023. The Company finished in the 68th percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2025. Therefore, the performance criteria and requirements for vesting have been satisfied at 116.5% of the target award level, and such number of shares vested on December 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2023, as disclosed in the Reporting Person's Form 4 filing on February 21, 2023. The Company finished in the 68th percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2025. Therefore, the performance criteria and requirements for vesting have been satisfied at 116.5% of the target award level, and such number of shares vested on December 31, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":24952},"source":{"system":"sec-edgar","filing":"0001193125-26-002257","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312526002257/ownership.xml","form_type":"4"}},{"id":951944,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2026-01-05T20:18:37.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":true,"shares":24952,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41670.621,"source":{"system":"sec-edgar","filing":"0001193125-26-002257","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312526002257/ownership.xml","form_type":"4"}},{"id":951943,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2026-01-05T20:18:37.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14310,"price":16.03,"value":229389.3,"ownership":{"direct":true},"balance_after":27360.621,"source":{"system":"sec-edgar","filing":"0001193125-26-002257","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312526002257/ownership.xml","form_type":"4"}},{"id":1027528,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2025-10-02T21:16:40.000Z","date":"2025-10-01","kind":"exercise","planned":false,"acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":1450,"derivative":{"underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001193125-25-228649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312525228649/ownership.xml","form_type":"4"}},{"id":1027527,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2025-10-02T21:16:40.000Z","date":"2025-10-01","kind":"exercise","planned":false,"acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16994.621,"source":{"system":"sec-edgar","filing":"0001193125-25-228649","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312525228649/ownership.xml","form_type":"4"}},{"id":1027526,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2025-10-02T21:16:40.000Z","date":"2025-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":276,"price":12.58,"value":3472.08,"ownership":{"direct":true},"balance_after":16718.621,"source":{"system":"sec-edgar","filing":"0001193125-25-228649","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000119312525228649/ownership.xml","form_type":"4"}},{"id":1074828,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2025-08-05T13:21:10.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":2150,"derivative":{"underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0000950170-25-102465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025102465/ownership.xml","form_type":"4"}},{"id":1074827,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2025-08-05T13:21:10.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16393.621,"source":{"system":"sec-edgar","filing":"0000950170-25-102465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025102465/ownership.xml","form_type":"4"}},{"id":1074826,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2025-08-05T13:21:10.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":99,"price":10.53,"value":1042.47,"ownership":{"direct":true},"balance_after":16294.621,"source":{"system":"sec-edgar","filing":"0000950170-25-102465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025102465/ownership.xml","form_type":"4"}},{"id":1159450,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2025-05-05T18:53:25.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":2650,"derivative":{"underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0000950170-25-063437","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025063437/ownership.xml","form_type":"4"}},{"id":1159449,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2025-05-05T18:53:25.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":2400,"derivative":{"underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0000950170-25-063437","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025063437/ownership.xml","form_type":"4"}},{"id":1159448,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2025-05-05T18:53:25.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16071.621,"source":{"system":"sec-edgar","filing":"0000950170-25-063437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025063437/ownership.xml","form_type":"4"}},{"id":1159447,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2025-05-05T18:53:25.000Z","date":"2025-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":79,"price":11.68,"value":922.72,"ownership":{"direct":true},"balance_after":15992.621,"source":{"system":"sec-edgar","filing":"0000950170-25-063437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025063437/ownership.xml","form_type":"4"}},{"id":1159446,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2025-05-05T18:53:25.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16242.621,"source":{"system":"sec-edgar","filing":"0000950170-25-063437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025063437/ownership.xml","form_type":"4"}},{"id":1159445,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2025-05-05T18:53:25.000Z","date":"2025-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":99,"price":11.68,"value":1156.32,"ownership":{"direct":true},"balance_after":16143.621,"source":{"system":"sec-edgar","filing":"0000950170-25-063437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025063437/ownership.xml","form_type":"4"}},{"id":1269803,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Performance Shares","published_at":"2025-02-13T21:44:21.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":32912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests following the conclusion of a three-year performance period that began on January 1, 2025 and ends on December 31, 2027 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, on January 1, 2028, following the conclusion of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (\"ROIC\") among the Bloomberg Peer Group (\"BPG\"), 100% of the award will vest if the Company is in the top 55th percentile of ROIC among the BPG, and 175% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile of ROIC (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile of ROIC (equivalent to 100% up to 175% of the award).\nThe number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half\nif absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at\nthe end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests following the conclusion of a three-year performance period that began on January 1, 2025 and ends on December 31, 2027 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, on January 1, 2028, following the conclusion of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (\"ROIC\") among the Bloomberg Peer Group (\"BPG\"), 100% of the award will vest if the Company is in the top 55th percentile of ROIC among the BPG, and 175% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."}],"balance_after":32912,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":32912},"source":{"system":"sec-edgar","filing":"0000950170-25-019972","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025019972/ownership.xml","form_type":"4"}},{"id":1315292,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Performance Shares","published_at":"2025-01-03T21:56:46.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":9604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2022, as disclosed in the Reporting Person's Form 4 filing on February 17, 2022.  The Company finished in the 52nd percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2024. Therefore, the performance criteria and requirements for vesting have been satisfied at 54.6% of the target award level, and such number of shares vested on December 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2022, as disclosed in the Reporting Person's Form 4 filing on February 17, 2022.  The Company finished in the 52nd percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2024. Therefore, the performance criteria and requirements for vesting have been satisfied at 54.6% of the target award level, and such number of shares vested on December 31, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9604},"source":{"system":"sec-edgar","filing":"0000950170-25-001310","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025001310/ownership.xml","form_type":"4"}},{"id":1315291,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2025-01-03T21:56:46.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":9604,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20899.621,"source":{"system":"sec-edgar","filing":"0000950170-25-001310","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025001310/ownership.xml","form_type":"4"}},{"id":1315290,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2025-01-03T21:56:46.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":5028,"price":17.31,"value":87034.68,"ownership":{"direct":true},"balance_after":15871.621,"source":{"system":"sec-edgar","filing":"0000950170-25-001310","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017025001310/ownership.xml","form_type":"4"}},{"id":1392298,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2024-10-03T18:13:14.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":2850,"derivative":{"underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0000950170-24-112230","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024112230/ownership.xml","form_type":"4"}},{"id":1392297,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-10-03T18:13:14.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11571.621,"source":{"system":"sec-edgar","filing":"0000950170-24-112230","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024112230/ownership.xml","form_type":"4"}},{"id":1392296,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-10-03T18:13:14.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":276,"price":19.21,"value":5301.96,"ownership":{"direct":true},"balance_after":11295.621,"source":{"system":"sec-edgar","filing":"0000950170-24-112230","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024112230/ownership.xml","form_type":"4"}},{"id":1440981,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2024-08-05T17:06:13.000Z","date":"2024-08-01","kind":"exercise","planned":false,"acquired":false,"shares":120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":3800,"derivative":{"underlying":"Common Stock","underlying_shares":120},"source":{"system":"sec-edgar","filing":"0000950170-24-090555","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024090555/ownership.xml","form_type":"4"}},{"id":1440980,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2024-08-05T17:06:13.000Z","date":"2024-08-01","kind":"exercise","planned":false,"acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":3550,"derivative":{"underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0000950170-24-090555","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024090555/ownership.xml","form_type":"4"}},{"id":1440979,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-08-05T17:06:13.000Z","date":"2024-08-01","kind":"exercise","planned":false,"acquired":true,"shares":120,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10768.621,"source":{"system":"sec-edgar","filing":"0000950170-24-090555","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024090555/ownership.xml","form_type":"4"}},{"id":1440978,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-08-05T17:06:13.000Z","date":"2024-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":48,"price":23.24,"value":1115.52,"ownership":{"direct":true},"balance_after":10720.621,"source":{"system":"sec-edgar","filing":"0000950170-24-090555","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024090555/ownership.xml","form_type":"4"}},{"id":1440977,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-08-05T17:06:13.000Z","date":"2024-08-01","kind":"exercise","planned":false,"acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10970.621,"source":{"system":"sec-edgar","filing":"0000950170-24-090555","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024090555/ownership.xml","form_type":"4"}},{"id":1440976,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-08-05T17:06:13.000Z","date":"2024-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":99,"price":23.24,"value":2300.76,"ownership":{"direct":true},"balance_after":10871.621,"source":{"system":"sec-edgar","filing":"0000950170-24-090555","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024090555/ownership.xml","form_type":"4"}},{"id":1530675,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2024-05-02T20:59:01.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":4170,"derivative":{"underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0000950170-24-052284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024052284/ownership.xml","form_type":"4"}},{"id":1530674,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2024-05-02T20:59:01.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":3920,"derivative":{"underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0000950170-24-052284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024052284/ownership.xml","form_type":"4"}},{"id":1530673,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-05-02T20:59:01.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10576.621,"source":{"system":"sec-edgar","filing":"0000950170-24-052284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024052284/ownership.xml","form_type":"4"}},{"id":1530672,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-05-02T20:59:01.000Z","date":"2024-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":79,"price":15.71,"value":1241.09,"ownership":{"direct":true},"balance_after":10497.621,"source":{"system":"sec-edgar","filing":"0000950170-24-052284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024052284/ownership.xml","form_type":"4"}},{"id":1530671,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-05-02T20:59:01.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10747.621,"source":{"system":"sec-edgar","filing":"0000950170-24-052284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024052284/ownership.xml","form_type":"4"}},{"id":1530670,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-05-02T20:59:01.000Z","date":"2024-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":99,"price":15.71,"value":1555.29,"ownership":{"direct":true},"balance_after":10648.621,"source":{"system":"sec-edgar","filing":"0000950170-24-052284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024052284/ownership.xml","form_type":"4"}},{"id":1641224,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Performance Shares","published_at":"2024-02-15T21:10:27.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":38002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period\nas follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award).\nThe number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period\nas follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award).\nThe number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."}],"balance_after":38002,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":38002},"source":{"system":"sec-edgar","filing":"0000950170-24-015883","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024015883/ownership.xml","form_type":"4"}},{"id":1684417,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-01-08T19:50:38.000Z","date":"2023-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2716,"price":17.66,"value":47964.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4, filed on January 3, 2024, is being amended by this Form 4 amendment to correct an administrative error of the issuer, whereupon the number of shares withheld to satisfy tax withholding obligations upon vesting of certain restricted performance shares was misreported as 2,654 shares.  The corrected transaction reflects an increase of 62 shares withheld by the issuer as a result such vesting and a corresponding reduction in the number of shares beneficially owned by the reporting person."}],"balance_after":10376.621,"source":{"system":"sec-edgar","filing":"0000950170-24-002893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024002893/ownership.xml","form_type":"4/A","original_submission_date":"2024-01-03"}},{"id":1693210,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Performance Shares","published_at":"2024-01-03T22:50:15.000Z","date":"2023-12-29","kind":"exercise","planned":false,"acquired":false,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4A filing on October 6, 2021. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2023 at the conclusion of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4A filing on October 6, 2021. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2023 at the conclusion of the performance period."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6900},"source":{"system":"sec-edgar","filing":"0000950170-24-001250","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024001250/ownership.xml","form_type":"4"}},{"id":1693209,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-01-03T22:50:15.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":true,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13092.621,"source":{"system":"sec-edgar","filing":"0000950170-24-001250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024001250/ownership.xml","form_type":"4"}},{"id":1693208,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2024-01-03T22:50:15.000Z","date":"2023-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2654,"price":17.66,"value":46869.64,"ownership":{"direct":true},"balance_after":10438.621,"source":{"system":"sec-edgar","filing":"0000950170-24-001250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017024001250/ownership.xml","form_type":"4"}},{"id":1724056,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2023-12-04T21:54:30.000Z","date":"2023-12-01","kind":"exercise","planned":false,"acquired":false,"shares":160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":4370,"derivative":{"underlying":"Common Stock","underlying_shares":160},"source":{"system":"sec-edgar","filing":"0000950170-23-067809","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017023067809/ownership.xml","form_type":"4"}},{"id":1724055,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-12-04T21:54:30.000Z","date":"2023-12-01","kind":"exercise","planned":false,"acquired":true,"shares":160,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6254.621,"source":{"system":"sec-edgar","filing":"0000950170-23-067809","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017023067809/ownership.xml","form_type":"4"}},{"id":1724054,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-12-04T21:54:30.000Z","date":"2023-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":62,"price":18.07,"value":1120.34,"ownership":{"direct":true},"balance_after":6192.621,"source":{"system":"sec-edgar","filing":"0000950170-23-067809","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017023067809/ownership.xml","form_type":"4"}},{"id":1767902,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2023-10-03T16:30:06.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":4530,"derivative":{"underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0000950170-23-051344","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017023051344/ownership.xml","form_type":"4"}},{"id":1767901,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-10-03T16:30:06.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6364.621,"source":{"system":"sec-edgar","filing":"0000950170-23-051344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017023051344/ownership.xml","form_type":"4"}},{"id":1767900,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-10-03T16:30:06.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":270,"price":24.01,"value":6482.7,"ownership":{"direct":true},"balance_after":6094.621,"source":{"system":"sec-edgar","filing":"0000950170-23-051344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000095017023051344/ownership.xml","form_type":"4"}},{"id":1818075,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2023-08-02T15:27:33.000Z","date":"2023-08-01","kind":"exercise","planned":false,"acquired":false,"shares":120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mulitple restricted share grants are included in this total."}],"balance_after":5480,"derivative":{"underlying":"Common Stock","underlying_shares":120},"source":{"system":"sec-edgar","filing":"0001209191-23-044117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123044117/doc4.xml","form_type":"4"}},{"id":1818074,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2023-08-02T15:27:33.000Z","date":"2023-08-01","kind":"exercise","planned":false,"acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mulitple restricted share grants are included in this total."}],"balance_after":5230,"derivative":{"underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001209191-23-044117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123044117/doc4.xml","form_type":"4"}},{"id":1818073,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-08-02T15:27:33.000Z","date":"2023-08-01","kind":"exercise","planned":false,"acquired":true,"shares":120,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5561.621,"source":{"system":"sec-edgar","filing":"0001209191-23-044117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123044117/doc4.xml","form_type":"4"}},{"id":1818072,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-08-02T15:27:33.000Z","date":"2023-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":47,"price":27.43,"value":1289.21,"ownership":{"direct":true},"balance_after":5514.621,"source":{"system":"sec-edgar","filing":"0001209191-23-044117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123044117/doc4.xml","form_type":"4"}},{"id":1818071,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-08-02T15:27:33.000Z","date":"2023-08-01","kind":"exercise","planned":false,"acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5764.621,"source":{"system":"sec-edgar","filing":"0001209191-23-044117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123044117/doc4.xml","form_type":"4"}},{"id":1818070,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-08-02T15:27:33.000Z","date":"2023-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":100,"price":27.43,"value":2743.0,"ownership":{"direct":true},"balance_after":5664.621,"source":{"system":"sec-edgar","filing":"0001209191-23-044117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123044117/doc4.xml","form_type":"4"}},{"id":1908512,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2023-05-03T00:31:22.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mulitple restricted share grants are included in this total."}],"balance_after":5850,"derivative":{"underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001209191-23-026793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123026793/doc4.xml","form_type":"4"}},{"id":1908511,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2023-05-03T00:31:22.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mulitple restricted share grants are included in this total."}],"balance_after":5600,"derivative":{"underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001209191-23-026793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123026793/doc4.xml","form_type":"4"}},{"id":1908510,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-05-03T00:31:22.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5365.621,"source":{"system":"sec-edgar","filing":"0001209191-23-026793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123026793/doc4.xml","form_type":"4"}},{"id":1908509,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-05-03T00:31:22.000Z","date":"2023-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":77,"price":22.03,"value":1696.31,"ownership":{"direct":true},"balance_after":5288.621,"source":{"system":"sec-edgar","filing":"0001209191-23-026793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123026793/doc4.xml","form_type":"4"}},{"id":1908508,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-05-03T00:31:22.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5538.621,"source":{"system":"sec-edgar","filing":"0001209191-23-026793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123026793/doc4.xml","form_type":"4"}},{"id":1908507,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Stock","published_at":"2023-05-03T00:31:22.000Z","date":"2023-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":97,"price":22.03,"value":2136.91,"ownership":{"direct":true},"balance_after":5441.621,"source":{"system":"sec-edgar","filing":"0001209191-23-026793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872069/000120919123026793/doc4.xml","form_type":"4"}},{"id":2004648,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Performance Shares","published_at":"2023-02-21T15:22:34.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":21418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2023 and ends on December 31, 2025 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2023 and ends on December 31, 2025 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."}],"balance_after":21418,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":21418},"source":{"system":"sec-edgar","filing":"0001209191-23-011101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919123011101/doc4.xml","form_type":"4"}},{"id":2098990,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2022-12-02T13:33:23.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mulitple restricted share grants are included in this total."}],"balance_after":6050,"derivative":{"underlying":"Common Shares","underlying_shares":160},"source":{"system":"sec-edgar","filing":"0001209191-22-059314","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122059314/doc4.xml","form_type":"4"}},{"id":2098989,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-12-02T13:33:23.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":160,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5228.621,"source":{"system":"sec-edgar","filing":"0001209191-22-059314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122059314/doc4.xml","form_type":"4"}},{"id":2098988,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-12-02T13:33:23.000Z","date":"2022-12-01","kind":"tax_withholding","acquired":false,"shares":63,"price":21.5,"value":1354.5,"ownership":{"direct":true},"balance_after":5165.621,"source":{"system":"sec-edgar","filing":"0001209191-22-059314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122059314/doc4.xml","form_type":"4"}},{"id":2147938,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2022-10-03T12:34:42.000Z","date":"2022-10-01","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mulitple restricted share grants are included in this total."}],"balance_after":6210,"derivative":{"underlying":"Common Shares","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001209191-22-051744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122051744/doc4.xml","form_type":"4"}},{"id":2147937,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-10-03T12:34:42.000Z","date":"2022-10-01","kind":"exercise","acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5344.621,"source":{"system":"sec-edgar","filing":"0001209191-22-051744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122051744/doc4.xml","form_type":"4"}},{"id":2147936,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-10-03T12:34:42.000Z","date":"2022-10-01","kind":"tax_withholding","acquired":false,"shares":276,"price":13.48,"value":3720.48,"ownership":{"direct":true},"balance_after":5068.621,"source":{"system":"sec-edgar","filing":"0001209191-22-051744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122051744/doc4.xml","form_type":"4"}},{"id":2198151,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2022-08-02T15:25:20.000Z","date":"2022-08-01","kind":"exercise","acquired":false,"shares":120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mulitple restricted share grants are included in this total."}],"balance_after":7160,"derivative":{"underlying":"Common Shares","underlying_shares":120},"source":{"system":"sec-edgar","filing":"0001209191-22-043831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122043831/doc4.xml","form_type":"4"}},{"id":2198150,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2022-08-02T15:25:20.000Z","date":"2022-08-01","kind":"exercise","acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mulitple restricted share grants are included in this total."}],"balance_after":6910,"derivative":{"underlying":"Common Shares","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001209191-22-043831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122043831/doc4.xml","form_type":"4"}},{"id":2198149,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-08-02T15:25:20.000Z","date":"2022-08-01","kind":"exercise","acquired":true,"shares":120,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4560.621,"source":{"system":"sec-edgar","filing":"0001209191-22-043831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122043831/doc4.xml","form_type":"4"}},{"id":2198148,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-08-02T15:25:20.000Z","date":"2022-08-01","kind":"tax_withholding","acquired":false,"shares":54,"price":18.02,"value":973.08,"ownership":{"direct":true},"balance_after":4506.621,"source":{"system":"sec-edgar","filing":"0001209191-22-043831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122043831/doc4.xml","form_type":"4"}},{"id":2198147,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-08-02T15:25:20.000Z","date":"2022-08-01","kind":"exercise","acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4756.621,"source":{"system":"sec-edgar","filing":"0001209191-22-043831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122043831/doc4.xml","form_type":"4"}},{"id":2198146,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-08-02T15:25:20.000Z","date":"2022-08-01","kind":"tax_withholding","acquired":false,"shares":112,"price":18.02,"value":2018.24,"ownership":{"direct":true},"balance_after":4644.621,"source":{"system":"sec-edgar","filing":"0001209191-22-043831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122043831/doc4.xml","form_type":"4"}},{"id":2286935,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2022-05-02T15:33:20.000Z","date":"2022-05-01","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mulitple restricted share grants are included in this total."}],"balance_after":7530,"derivative":{"underlying":"Common Shares","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001209191-22-026397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122026397/doc4.xml","form_type":"4"}},{"id":2286934,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2022-05-02T15:33:20.000Z","date":"2022-05-01","kind":"exercise","acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mulitple restricted share grants are included in this total."}],"balance_after":7280,"derivative":{"underlying":"Common Shares","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001209191-22-026397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122026397/doc4.xml","form_type":"4"}},{"id":2286933,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-05-02T15:33:20.000Z","date":"2022-05-01","kind":"exercise","acquired":true,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4364.621,"source":{"system":"sec-edgar","filing":"0001209191-22-026397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122026397/doc4.xml","form_type":"4"}},{"id":2286932,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-05-02T15:33:20.000Z","date":"2022-05-01","kind":"tax_withholding","acquired":false,"shares":77,"price":26,"value":2002.0,"ownership":{"direct":true},"balance_after":4287.621,"source":{"system":"sec-edgar","filing":"0001209191-22-026397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122026397/doc4.xml","form_type":"4"}},{"id":2286931,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-05-02T15:33:20.000Z","date":"2022-05-01","kind":"exercise","acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4537.621,"source":{"system":"sec-edgar","filing":"0001209191-22-026397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122026397/doc4.xml","form_type":"4"}},{"id":2286930,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-05-02T15:33:20.000Z","date":"2022-05-01","kind":"tax_withholding","acquired":false,"shares":97,"price":26,"value":2522.0,"ownership":{"direct":true},"balance_after":4440.621,"source":{"system":"sec-edgar","filing":"0001209191-22-026397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122026397/doc4.xml","form_type":"4"}},{"id":2362333,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2022-03-02T16:21:57.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vest date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vest date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":7730,"derivative":{"underlying":"Common Shares","underlying_shares":110},"source":{"system":"sec-edgar","filing":"0001209191-22-014727","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122014727/doc4.xml","form_type":"4"}},{"id":2362332,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-03-02T16:21:57.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":110,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4214.621,"source":{"system":"sec-edgar","filing":"0001209191-22-014727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122014727/doc4.xml","form_type":"4"}},{"id":2362331,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2022-03-02T16:21:57.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":50,"price":27.51,"value":1375.5,"ownership":{"direct":true},"balance_after":4164.621,"source":{"system":"sec-edgar","filing":"0001209191-22-014727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122014727/doc4.xml","form_type":"4"}},{"id":2389568,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Performance Shares","published_at":"2022-02-17T17:11:06.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":17588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2022 and ends on December 31, 2024 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause, termination by the employee for \"good reason\" (as defined in the employee's employment agreement), or retirement by the employee upon having reached 62 years of age.  The shares would vest, if at all, at the end of the Performance Period as follows: (i) 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (\"BPG\"); (ii) 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG; or (iii) 150% of the award will vest if the Company is the top performing ROIC company of the BPG, all as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These awards will be interpolated on a straight-line basis from the 50th percentile to the 100th percentile. The amount that vests over the 100% of the award up to the maximum 150% of the award, if any, is subject to a reduction of one-half of the final percentage above 100% if absolute Total Share Return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2022 and ends on December 31, 2024 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause, termination by the employee for \"good reason\" (as defined in the employee's employment agreement), or retirement by the employee upon having reached 62 years of age.  The shares would vest, if at all, at the end of the Performance Period as follows: (i) 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (\"BPG\"); (ii) 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG; or (iii) 150% of the award will vest if the Company is the top performing ROIC company of the BPG, all as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These awards will be interpolated on a straight-line basis from the 50th percentile to the 100th percentile. The amount that vests over the 100% of the award up to the maximum 150% of the award, if any, is subject to a reduction of one-half of the final percentage above 100% if absolute Total Share Return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."}],"balance_after":17588,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":17588},"source":{"system":"sec-edgar","filing":"0001209191-22-010876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122010876/doc4.xml","form_type":"4"}},{"id":2487024,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2021-12-03T10:23:18.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Shares vest annually over six year on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vest date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest annually over six year on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest annually over six year on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vest date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":7840,"derivative":{"underlying":"Common Shares","underlying_shares":160},"source":{"system":"sec-edgar","filing":"0001209191-21-067729","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121067729/doc4.xml","form_type":"4"}},{"id":2487023,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2021-12-03T10:23:18.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":160,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4143.621,"source":{"system":"sec-edgar","filing":"0001209191-21-067729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121067729/doc4.xml","form_type":"4"}},{"id":2487022,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2021-12-03T10:23:18.000Z","date":"2021-12-01","kind":"tax_withholding","acquired":false,"shares":39,"price":22.41,"value":873.99,"ownership":{"direct":true},"balance_after":4104.621,"source":{"system":"sec-edgar","filing":"0001209191-21-067729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121067729/doc4.xml","form_type":"4"}},{"id":2547523,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Performance Shares","published_at":"2021-10-06T18:51:51.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, this award would vest at the end of a three-year performance period that began on January 1, 2021 and ends on December 31, 2023 (the \"Performance Period\"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return On Invested Capital of the Bloomberg Peer Group as measured and determined by the Compensation Committee at the end of the  Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, this award would vest at the end of a three-year performance period that began on January 1, 2021 and ends on December 31, 2023 (the \"Performance Period\"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return On Invested Capital of the Bloomberg Peer Group as measured and determined by the Compensation Committee at the end of the  Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, this award would vest at the end of a three-year performance period that began on January 1, 2021 and ends on December 31, 2023 (the \"Performance Period\"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return On Invested Capital of the Bloomberg Peer Group as measured and determined by the Compensation Committee at the end of the  Performance Period."}],"balance_after":6900,"derivative":{"underlying":"Common Shares","underlying_shares":6900},"source":{"system":"sec-edgar","filing":"0001209191-21-059865","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121059865/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2547522,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2021-10-06T18:51:51.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":7320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Mr. Tattoli has 6 grants of Restricted Shares outstanding as of July 2, 2021, and of those the following shares remain unvested as of such date: 110 shares from the grant on March 1, 2016, 480 shares from the grant on December 1, 2017, 480 shares from the grant on August 1, 2018, 800 shares from the grant on May 1, 2019, 1,250 shares from the grant on May 1, 2020, and 4,200 shares from the grant on October 1, 2020. The Restricted Shares granted will vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Mr. Tattoli has 6 grants of Restricted Shares outstanding as of July 2, 2021, and of those the following shares remain unvested as of such date: 110 shares from the grant on March 1, 2016, 480 shares from the grant on December 1, 2017, 480 shares from the grant on August 1, 2018, 800 shares from the grant on May 1, 2019, 1,250 shares from the grant on May 1, 2020, and 4,200 shares from the grant on October 1, 2020. The Restricted Shares granted will vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Mr. Tattoli has 6 grants of Restricted Shares outstanding as of July 2, 2021, and of those the following shares remain unvested as of such date: 110 shares from the grant on March 1, 2016, 480 shares from the grant on December 1, 2017, 480 shares from the grant on August 1, 2018, 800 shares from the grant on May 1, 2019, 1,250 shares from the grant on May 1, 2020, and 4,200 shares from the grant on October 1, 2020. The Restricted Shares granted will vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":7320,"derivative":{"underlying":"Common Shares","underlying_shares":7320},"source":{"system":"sec-edgar","filing":"0001209191-21-059865","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121059865/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2547521,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2021-10-06T18:51:51.000Z","date":"2021-08-01","kind":"exercise","acquired":false,"shares":120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents the time-based vesting of 120 shares from a grant of 720 Restricted Shares awarded to Mr. Tattoli on August 1, 2018. The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents the time-based vesting of 120 shares from a grant of 720 Restricted Shares awarded to Mr. Tattoli on August 1, 2018. The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents the time-based vesting of 120 shares from a grant of 720 Restricted Shares awarded to Mr. Tattoli on August 1, 2018. The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":7200,"derivative":{"underlying":"Common Shares","underlying_shares":120},"source":{"system":"sec-edgar","filing":"0001209191-21-059865","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121059865/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2547520,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2021-10-06T18:51:51.000Z","date":"2021-08-01","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Restricted Shares granted will vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Shares granted will vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Shares granted will vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":8700,"derivative":{"underlying":"Common Shares","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001209191-21-059865","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121059865/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2547519,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Restricted Shares","published_at":"2021-10-06T18:51:51.000Z","date":"2021-10-01","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents the time-based vesting of 700 shares from a grant of 4,200 Restricted Shares awarded to Mr. Tattoli on October 1, 2020. The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the time-based vesting of 700 shares from a grant of 4,200 Restricted Shares awarded to Mr. Tattoli on October 1, 2020. The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents the time-based vesting of 700 shares from a grant of 4,200 Restricted Shares awarded to Mr. Tattoli on October 1, 2020. The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":8000,"derivative":{"underlying":"Common Shares","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001209191-21-059865","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121059865/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2547518,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2021-10-06T18:51:51.000Z","date":"2021-10-01","kind":"tax_withholding","acquired":false,"shares":169,"price":29.05,"value":4909.45,"ownership":{"direct":true},"balance_after":3983.621,"source":{"system":"sec-edgar","filing":"0001209191-21-059865","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121059865/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}},{"id":2547517,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":26699,"kind":"person","name":"Tattoli Mark Damian","position":1,"cik":"0001872069","reported_name":"Tattoli Mark Damian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Secretary"}}],"security":"Common Shares","published_at":"2021-10-06T18:51:51.000Z","date":"2021-10-01","kind":"exercise","acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4152.621,"source":{"system":"sec-edgar","filing":"0001209191-21-059865","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121059865/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-05"}}],"next_cursor":"2021-10-06T18:51:51.000000Z,2547517"}